Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Chemsyn Pharm CoBJSE:920656 36 Market Cap is ¥1,370.0 Mil as of Jul. 14, 2026. GuruFocus rates BJSE:920656 with a GF Score™ of 36/100. The stock has 4 warning signs investors should review. Among 18 Healthcare Plans companies, Zhejiang Chemsyn Pharm Co ranks worse than 83.33% on this metric.
Zhejiang Chemsyn Pharm Co's quarterly market cap
declined
from Sep. 2025 (¥1,913.0 Mil) to Dec. 2025 (¥1,746.0 Mil) and
declined
from Dec. 2025 (¥1,746.0 Mil) to Mar. 2026 (¥1,537.0 Mil).
Zhejiang Chemsyn Pharm Co's annual market cap
increased
from Dec. 2023 (¥0.0 Mil) to Dec. 2024 (¥1,248.0 Mil) and
increased
from Dec. 2024 (¥1,248.0 Mil) to Dec. 2025 (¥1,746.0 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zhejiang Chemsyn Pharm Co's Enterprise Value for Today is ¥933.9 Mil.
Zhejiang Chemsyn Pharm Co (BJSE:920656) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Zhejiang Chemsyn Pharm Co Market Cap Related Terms
Zhejiang Chemsyn Pharm Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920656 vs UNH, CVS, ELV: Market Cap Comparison
For the Healthcare Plans subindustry, Zhejiang Chemsyn Pharm Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Chemsyn Pharm Co Market Cap vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Zhejiang Chemsyn Pharm Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Zhejiang Chemsyn Pharm Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a Market Cap of ¥1,370.0 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. According to the industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #15 out of 18 companies in the Healthcare Plans industry, placing it in the top 83.3%.
Is Zhejiang Chemsyn Pharm Co's Market Cap too high?
Zhejiang Chemsyn Pharm Co's current Market Cap is ¥1,370.0 Mil. Based on the distribution chart, Zhejiang Chemsyn Pharm Co ranks #15 out of 18 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's Market Cap compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #15 out of 18 companies for Market Cap. This places Zhejiang Chemsyn Pharm Co in the lower half of its industry. The industry median Market Cap is 3,360.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Plans company?
The median Market Cap among Healthcare Plans companies is 3,360.19, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. For the Healthcare Plans industry, the median Market Cap is 3,360.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Chemsyn Pharm Co's current Market Cap is ¥1,370.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a current Market Cap of ¥1,370.0 Mil. The current Market Cap is ¥1,370.0 Mil. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current Market Cap is ¥1,370.0 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
36GF Score
Get the complete analysis for BJSE:920656
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920656 has been successfully added to your 
